About Us

About Us

The Australian Prostate Cancer Research Centre–Queensland (APCRC-Q) is a Brisbane-based multidisciplinary research centre dedicated to prostate cancer research.

The Australian Prostate Cancer Research Centre–Queensland (APCRC-Q) is a highly collaborative, disease-specific research centre, focusing on the development of new therapeutics and biomarkers for prostate cancer and their translation into the clinical setting.

Established in 2009 with the aid of a $15.2 million grant from the Australian Government, Department of Health and Ageing, the Centre is led by Professor Colleen Nelson. With more than 65 academic and clinical faculty, researchers and trainees, APCRC-Q spans the full spectrum of prostate cancer research - including discovery, diagnostic and therapeutic development, and health services. The Centre's research is informed by data from real patient samples with discoveries tested in clinically relevant models. New therapies are then delivered back to patients through clinical trials. APCRC-Q hosts the Prostate Cancer Outcomes Registry - Queensland and launched the Multidisciplinary Team Clinic (MDT) for Advanced Prostate Cancer in 2009.

APCRC-Q is a joint initiative between Queensland University of Technology (QUT) and the Princess Alexandra Hospital. Researchers at APCRC-Q have a strong focus on the translation of prostate cancer research from bench to bedside, which is greatly enhanced by the Centre’s location within the Translational Research Institute (TRI) situated on the Princess Alexandra Hospital Campus.  

Focused exclusively on prostate cancer, APCRC-Q forms a hub for prostate cancer research in Brisbane. The Centre's multidisciplinary framework integrates research activities from discovery through to clinical trials, with affiliate researchers at Queensland University of Technology, University of Queensland, Griffith University, Princess Alexandra Hospital, and other institutes across Australia and around the world.